Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: A pharmacogenetic approach
The DOI matches its Crossref record.
Abstract
Trimethylamine N-oxide (TMAO), which is naturally occurring in dietary marine fish, is well absorbed and excreted apparently unchanged as judged by end-product analysis. Such observations may conceal the fact that the amine N-oxide has undergone a sequence of deoxygenation and oxygenation reactions only to revert to the parental form and be excreted as such—a process that we propose to call metabolic retroversion. To evaluate this phenomenon for TMAO we have investigated the fate of the orally administered substance in healthy volunteers and in four subjects previously phenotyped as having an inherited deficiency with respect to the metabolic N-oxidation of trimethylamine (TMA). Two of these subjects were typed as homozygous affected and the other two as “carriers.” If substantial reduction of orally administered TMAO occurs during the course of its postulated retroverted metabolism, it was hypothesized that this would be revealed by the extensive urinary excretion of unoxidized TMA by the four affected subjects. After oral TMAO administration in the four healthy subjects, >94% of the urinary TMA was in the form of TMAO and only <4% as the free base. However, after oral TMAO in the two homozygous-affected subjects, unoxidized TMA accounted for 35% and 51%, respectively, of the total urinary TMA, the balance being due to TMAO. For the carrier subjects, TMA accounted for 12% and 16% of the total urinary TMA after TMAO administration. It is thus clear that the urinary excretion of unoxidized TMA is increased greatly in affected subjects with an inherited deficiency of N-oxidation after the oral administration of TMAO. For the subjects investigated it appears that some 40% to 60% of an oral dose of TMAO undergoes reduction as part of the retroverted metabolic process. It is proposed that the use of human metabolic variants allows both a qualitative and quantitative assessment of retroverted metabolism as occurs with TMAO, and the principle may usefully be applied in other situations. Clinical Pharmacology and Therapeutics (1987) 42, 608–612; doi:10.1038/clpt.1987.207
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303
Pharmacokinetics of L-Carnitine
Evans, A. M., & Fornasini, G. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342110-00002 · Cited by 301
Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome
Dolphin, C. T., Janmohamed, A., Smith, R. L., Shephard, E. A., & Phillips, L. R. (1997) · Nature Genetics · doi:10.1038/ng1297-491 · Cited by 284
Self-citationDietary Precursors of Trimethylamine in Man: A Pilot Study
Zhang, A. Q., Mitchell, S. C., & Smith, R. L. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00028-9 · Cited by 232
Self-citationBell, J. D., Lee, J. A., Lee, H. A., Sadler, P. J., Wilkie, D. R., & Woodham, R. H. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90046-c · Cited by 147
Metadata
- Authors
- Al-Waiz, M., Ayesh, R., Mitchell, S. C., Idle, J. R., & Smith, R. L.
- Venue
- Clinical Pharmacology and Therapeutics
- Publisher
- Wiley
- Published
- 1987-12
- Volume
- 42
- Issue
- 6
- Pages
- 608-612
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1974993590
- Cited by
- 56
- References
- 0
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: A pharmacogenetic approach. https://app.cochat.ai/papers/10.1038/clpt.1987.207
- The paper
- Al-Waiz, M., Ayesh, R., Mitchell, S. C., Idle, J. R., & Smith, R. L. (1987). Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: A pharmacogenetic approach. Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.1987.207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.